Dyspnea on mild exertion ... The clinical impression was pericarditis and myocarditis with cardiac decompensation. The patient was placed on salt restriction and digitalized during the first ...

In addition to pharmacologic interventions and oxygen, there are a number of nonpharmacologic strategies that can be beneficial in the management of dyspnea. By changing a patient's physical ...

NEW research has revealed that myocarditis is a significant consequence of COVID-19, with over half of the recovered patients showing cardiac injury through cardiac magnetic resonance (CMR) imaging.

He had been experiencing symptoms including asthenia, adynamia, dyspnea and chest pain for at least 1 day prior to admission ... Additionally, target temperature management was implemented at ...

The fly in the ointment was a case of myocarditis – inflammation of the heart muscle – that was seen in an 11-year-old boy enrolled in Study 9001-103 and was deemed to be serious. Treatment ...

Infective endocarditis (IE) is by far the most common cardiovascular infection worldwide. Despite the medical and surgical advances, this condition remains associated with considerable mortality ...

After more than six years, researchers have discovered that the answer is yes. Their research shows that myocarditis — a form of heart inflammation sometimes triggered by immunotherapy — is ...

Acute myocarditis is an inflammatory disease of the heart muscle that may progress to dilated cardiomyopathy and chronic heart failure. A number of factors including the sex hormone testosterone, ...

Cancer immunotherapy has redefined the treatment of many cancers, but in a small number of patients this life-saving approach also leads to a dangerous heart-muscle inflammation called myocarditis.

Department of Medicine, Advocate Lutheran General Hospital, Park Ridge, IL, United States Although anxiety is a common psychological condition, its symptoms are related to a cardiopulmonary strain ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...